[
  {
    "ts": "2025-12-10T10:52:03+00:00",
    "headline": "Here's What We Like About Gilead Sciences' (NASDAQ:GILD) Upcoming Dividend",
    "summary": "Gilead Sciences, Inc. ( NASDAQ:GILD ) stock is about to trade ex-dividend in 4 days. The ex-dividend date is one...",
    "url": "https://finance.yahoo.com/news/heres-gilead-sciences-nasdaq-gild-105203738.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "80c5c376-acd1-3448-b36e-3455768f16ea",
      "content": {
        "id": "80c5c376-acd1-3448-b36e-3455768f16ea",
        "contentType": "STORY",
        "title": "Here's What We Like About Gilead Sciences' (NASDAQ:GILD) Upcoming Dividend",
        "description": "",
        "summary": "Gilead Sciences, Inc. ( NASDAQ:GILD ) stock is about to trade ex-dividend in 4 days. The ex-dividend date is one...",
        "pubDate": "2025-12-10T10:52:03Z",
        "displayTime": "2025-12-10T10:52:03Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/34a971ca153ed4a9b10f7d789bca1b9d",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/HAEiJmFsYXJTRBPxnneP6w--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/34a971ca153ed4a9b10f7d789bca1b9d.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/hXB9F2qU7k4qk3_k1DQd9A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/34a971ca153ed4a9b10f7d789bca1b9d.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/heres-gilead-sciences-nasdaq-gild-105203738.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/heres-gilead-sciences-nasdaq-gild-105203738.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GILD"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-10T16:28:46+00:00",
    "headline": "Cantor Fitzgerald Maintains a Buy Rating on Gilead Sciences (GILD)",
    "summary": "Gilead Sciences, Inc. (NASDAQ:GILD) is one of the best pharma stocks to invest in. Cantor Fitzgerald analyst Carter Gould maintained a Buy rating on Gilead Sciences, Inc. (NASDAQ:GILD) on December 7, setting a price target of $135. The same day, Kite, a Gilead Sciences, Inc. (NASDAQ:GILD) company, released a new analysis showing that second-line Yescarta therapy […]",
    "url": "https://finance.yahoo.com/news/cantor-fitzgerald-maintains-buy-rating-162846108.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "746e1dbf-dd93-3bbe-b4cb-76d79cec6280",
      "content": {
        "id": "746e1dbf-dd93-3bbe-b4cb-76d79cec6280",
        "contentType": "STORY",
        "title": "Cantor Fitzgerald Maintains a Buy Rating on Gilead Sciences (GILD)",
        "description": "",
        "summary": "Gilead Sciences, Inc. (NASDAQ:GILD) is one of the best pharma stocks to invest in. Cantor Fitzgerald analyst Carter Gould maintained a Buy rating on Gilead Sciences, Inc. (NASDAQ:GILD) on December 7, setting a price target of $135. The same day, Kite, a Gilead Sciences, Inc. (NASDAQ:GILD) company, released a new analysis showing that second-line Yescarta therapy […]",
        "pubDate": "2025-12-10T16:28:46Z",
        "displayTime": "2025-12-10T16:28:46Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/11c0338c5011aa20a9d44b77386b4a12",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "Why Gilead Sciences (GILD) Deserves Attention in the Cheap Quarterly Dividend Stocks Category",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ha22PhpGlsEhK3tmOzGDVw--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/11c0338c5011aa20a9d44b77386b4a12.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/CkBvnQJGKRIUyIDAWZszGw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/11c0338c5011aa20a9d44b77386b4a12.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/cantor-fitzgerald-maintains-buy-rating-162846108.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/cantor-fitzgerald-maintains-buy-rating-162846108.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GILD"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]